bpc-157 compounding restrictions fda Exciting news for peptides coming out of today's committee hearing! The Pharmacy Advisory Committee voted 8-6 to recommend adding BPC- 157 to the 503A Bulks List for use in compounding for A step towards expanded patient
A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and BPC 157 approved by FDA today to add as a compounded substance : r PeptidePathways FDA Discusses Peptide Bulk Substances BPC 157 and More Hillary Lin, MD posted on the topic LinkedIn
Pay in 4 interest-free payments of $6.83 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
